Schedule 13G ownership disclosure

MEREO BIOPHARMA GROUP PLC

Security class unavailable · CUSIP: 589492107

Event date: 2023-07-03

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
6.3800%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001172661-24-001209
Form type
SC 13G/A
Filer
Mereo BioPharma Group plc
CIK
CIK 1719714
Filed
Feb 14, 2024
Reporting period
Jul 03, 2023
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub